Ensign Peak Advisors, Inc

SEC CIK: 0001454984
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overview All 13F holders of KALV Full Q2 2026 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of KALV by Ensign Peak Advisors, Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−47,116−100.0%	Sold out	Holders
Q2 2021	47,116	$1.13M	<0.1%	00.0%	Unchanged	Holders
Q1 2021	47,116	$1.21M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.